Enhanced radiosensitivity of androgen-resistant prostate cancer: AZD1152-mediated Aurora kinase B inhibition.
Niermann, Kenneth J
Enhanced radiosensitivity of androgen-resistant prostate cancer: AZD1152-mediated Aurora kinase B inhibition. [electronic resource] - Radiation research Apr 2011 - 444-51 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
1938-5404
10.1667/RR2317.1 doi
Androgens--therapeutic use
Aurora Kinase B
Aurora Kinases
Cell Line, Tumor
Dose-Response Relationship, Drug
Humans
Male
Organophosphates--administration & dosage
Prostatic Neoplasms--drug therapy
Protein Serine-Threonine Kinases--antagonists & inhibitors
Quinazolines--administration & dosage
Radiation Tolerance--drug effects
Treatment Failure
Treatment Outcome
Enhanced radiosensitivity of androgen-resistant prostate cancer: AZD1152-mediated Aurora kinase B inhibition. [electronic resource] - Radiation research Apr 2011 - 444-51 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
1938-5404
10.1667/RR2317.1 doi
Androgens--therapeutic use
Aurora Kinase B
Aurora Kinases
Cell Line, Tumor
Dose-Response Relationship, Drug
Humans
Male
Organophosphates--administration & dosage
Prostatic Neoplasms--drug therapy
Protein Serine-Threonine Kinases--antagonists & inhibitors
Quinazolines--administration & dosage
Radiation Tolerance--drug effects
Treatment Failure
Treatment Outcome